Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/08/2003CN1123359C Treatment of cerebral ischomia and cerebral damage with neuroprotective agent
10/08/2003CN1123345C Compsns. of treating ARDS or IRDS
10/08/2003CN1123342C Use of inhibitors of renin-angiotension system
10/08/2003CN1123293C Moisture bacteriocin disinfectant wipes and methods of using same
10/07/2003USH2085 High molecular weight polypeptides used to screen for enzyme inhibitors, such as transferases, hydrolases or proteolytic enzymes; antibiotic resistance
10/07/2003US6630619 Insecticides; insecticidal proteins; genetic engineering; nematodes; symbionic bacteria; use of isolated polynucleotide encoding insecticidal protein to transform insect-specific viruses, bacteria, yeasts and plants to control insect pests
10/07/2003US6630613 Mouse whose genome comprises a disruption of large tumor suppressor (lats) protein; use in treatment of cancer and hyperproliferative disorders; use antagonists in growing larger animals and plants
10/07/2003US6630582 Isolated nucleic acid, of given sequence, which encodes a catalase; gastroduodenal diseases
10/07/2003US6630576 Mutated forms of hIL13 conjugated to cytotoxins are used to preferentially target diseased cells over non-diseased cells
10/07/2003US6630574 Compositions and methods for the therapy and diagnosis of lung cancer
10/07/2003US6630573 Tau-conotoxin peptides
10/07/2003US6630572 Thrombin derived polypeptides: compositions and methods for use
10/07/2003US6630570 Of tumor cells and tissues; derived from vaso-active intestinal protein, somatostatin or neurotensin; methine/cyanine; useful for endoscopy
10/07/2003US6630513 Capable of lowering plasma cholesterol levels and inhibiting abnormal cell proliferation, such as in cervical adenocarcinoma
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630487 Treatment of insulin resistance with growth hormone secretagogues
10/07/2003US6630486 Containing calcium sulfate
10/07/2003US6630480 Methods of treating leukemia
10/07/2003US6630456 Infecting a cell with infectious pancreatic necrosis virus
10/07/2003US6630451 Benzimidazolone peptidometics as thrombin receptor antagonist
10/07/2003US6630450 Method of treating dyslipidemia
10/07/2003US6630449 Administering vitamins, adrenocorticotropin and a mild relaxant, for example GABA precursors
10/07/2003US6630448 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/07/2003US6630447 Therapy for hematopoietic neoplasma
10/07/2003US6630445 Unglycosylated recombinant human alpha-fetoprotein made in a prokaryote (e.g., E. coli)
10/07/2003US6630444 Increasing amino acid and sugar absorption
10/07/2003US6630443 Detecting agonists and antagonists; treating under- and overexpression
10/07/2003US6630442 Reparatives for chemosurgery and laser (thermal) therapy
10/07/2003US6630351 Transfecting a cell by attaching a reversible labile membrane activity inhibitor to a melittin peptide; adding peptide to solution containing the nucleic acid; endocytosis
10/07/2003US6630349 Trophoblast cell preparations
10/07/2003US6630348 Single-chain insulin analog and a polynucleotide sequence encoding the analog
10/07/2003US6630345 Isolated DNA soup from amino acid sequence 1 or 2
10/07/2003US6630344 Adenoviral vectors; use for gene therapy, vaccines and for the transformation of cells
10/07/2003US6630336 Peptides; for use as tools in human therapeutics and diagnostic testing
10/07/2003US6630327 Methods and reagents for preparing and using immunological agents specific for P-glycoprotein
10/07/2003US6630326 Cancer diagnosis and therapy based on mutations in TGF-β receptors
10/07/2003US6630320 Prepared with trypsin; oral administration; given physical properties
10/07/2003US6630313 Phosphatidyl serine receptors and uses thereof
10/07/2003US6630312 Method for identifying compounds for treatment of insulin resistance
10/07/2003US6630305 Compositions and methods for the therapy and diagnosis of prostate cancer
10/07/2003US6630178 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
10/07/2003US6630171 Polypeptide polymers of aspartic acid and glutamic acid bearing a hydrophobic group; drug delivery; insulin carrier
10/07/2003US6630148 Amino acid sequence binds to naturally occurring patched receptor; generate and/or maintain an array of vertebrate tissue; expression of secondary signaling molecules, such as Transforming Growth Factors and fibroblast growth factors
10/07/2003US6630147 Pseudomycin natural products
10/07/2003US6630143 Monoclonal antibodes, treating hematopoietic disorders, in particular, aplastic anemia and myelodysplastic syndromes
10/07/2003US6630142 Reducing cell proliferation; obtain sample, incubate with antagonist, monitor sample for reduced cell proliferation
10/07/2003US6630141 Purified DNA including a sequence encoding an Ikaros protein; Alzheimer's disease; differentiation and generation of T cells
10/07/2003US6630140 Compositions and methods for treatment of asthma
10/07/2003US6630139 Fibrinogenolytic proteases with thrombolytic and antihypertensive activities: medical application and novel process of expression and production
10/07/2003US6630138 Protein C derivatives
10/07/2003US6630137 Lyophilized; a salt, bulking agent, buffer
10/07/2003US6630124 Combination therapy with VIP antagonist
10/07/2003US6630121 Supercritical fluid-assisted nebulization and bubble drying
10/07/2003US6630120 Co-administering intravascularly a bradykinin agonist that increases the transport of said substance from the bloodstream to the internal spaces of said non-central nervous system solid tumor
10/07/2003US6629970 Method of restoring endothelium of cornea
10/07/2003CA2211204C Prostaglandin receptor dp
10/07/2003CA2207286C Localized delivery of factors enhancing survival of transplanted cells
10/07/2003CA2132540C A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
10/07/2003CA2123685C Medicament for promoting growth of mammalian nerve
10/07/2003CA2074153C Seroreactive regions on hpv 16 proteins e1 and e2
10/07/2003CA1341443C Human c3b/c4b receptor (cr1) (the)
10/05/2003CA2424297A1 Human transferrin for the treatment of anemia of chronic disease (acd) and of functional iron deficiency
10/02/2003WO2003081258A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
10/02/2003WO2003081257A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1)
10/02/2003WO2003081250A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003WO2003081246A1 Treatment of congestive heart failure with natriuretic peptide and a diuretic
10/02/2003WO2003081242A1 Caspr3: modulators of angiogenesis
10/02/2003WO2003081238A2 Cytocapacity test
10/02/2003WO2003080856A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003WO2003080853A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003WO2003080852A1 Process for the preparation of a desired erythropoietin glyco-isoform profile
10/02/2003WO2003080847A1 Cationic amphiphiles for intracellular delivery of therapeutic molecules its composition, process and use thereof
10/02/2003WO2003080836A1 Nerve regeneration genes
10/02/2003WO2003080835A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003WO2003080831A1 Nuclear receptor errϝ3
10/02/2003WO2003080808A2 Novel compositions and methods in cancer
10/02/2003WO2003080807A2 Compositions and methods for suppressing eukaryotic gene expression
10/02/2003WO2003080797A2 6 human secreted proteins
10/02/2003WO2003080794A2 Inhibition of rna function by delivery of inhibitors to animal cells
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080667A2 A novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
10/02/2003WO2003080666A2 An adipocyte insulin and a method of treating diabetes
10/02/2003WO2003080663A2 Tenascin-w compositions and uses thereof
10/02/2003WO2003080662A1 Protein kinase c modulators, their aminoacid and nucleotide sequences and uses thereof
10/02/2003WO2003080661A1 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases
10/02/2003WO2003080659A1 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
10/02/2003WO2003080657A2 Yeast pheromones for the treatment of infectious diseases
10/02/2003WO2003080654A2 Helicobacter flagellar, motility polypeptides
10/02/2003WO2003080652A1 Antimicrobial peptide, its analogs and antimicrobial composition comprising them
10/02/2003WO2003080646A2 Modified plasminogen activator inhibitor type-1 and methods based thereon
10/02/2003WO2003080644A2 Novel method for the direct and regulated transfer of genetic material between cells
10/02/2003WO2003080640A1 Lymphatic and blood endothelial cell genes
10/02/2003WO2003080639A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003WO2003080638A2 Antisense iap nucleobase oligomers and uses thereof
10/02/2003WO2003080602A1 Maleic acid salt of (2s)-n-{5-[amino(imino)methyl]-2-thienyl}methyl-1-{(2r)-2-[(carboxymethyl)amino]3,3-diphenylpropanoyl}-2-pyrrolidine carboxamide and a process for
10/02/2003WO2003080601A1 New crystalline forms of (2s)-n-5-[amino(imino)methyl]-2-thienylmethyl-1-(2r)-2-[(carboxymethyl)amino]-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o
10/02/2003WO2003080569A2 Egfr ligands and methods of use
10/02/2003WO2003080116A1 Modulating angiogenesis
10/02/2003WO2003080110A1 Topical pathogenic-tissue-destroying liquid
10/02/2003WO2003080109A1 Use of hydrogen peroxide producing enzyme for treatment of otitis media
1 ... 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 1777 ... 3163